Animal Therapeutics And Diagnostics Market Report 2026

Animal Therapeutics And Diagnostics Market Overview

• Animal Therapeutics And Diagnostics market size has reached to $51.62 billion in 2025 • Expected to grow to $72.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Surge In Pet Adoption To Drive Market Growth • Market Trend: Digital Health And Telemedicine Reshaping The Animal Therapeutics And Diagnostics Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Animal Therapeutics And Diagnostics Market?

Animal therapeutics refers to the application of medical procedures to enhance an animal's health, whereas animal diagnostics deals with the recognition and analysis of ailments that affect animals. The main animal therapeutics and diagnostics animal types are companion animals, cattle, pigs, and poultry. Companion animals refer to tame or domestic-bred animals whose social needs can be readily met as companions in the home, or close daily connection with humans. The various products are animal diagnostics products, instruments, consumables, animal therapeutics products, anti-parasitic drugs and antibiotics, anti-inflammatory drugs, and anesthetics.

What Is The Animal Therapeutics And Diagnostics Market Growth Forecast?

The animal therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $72.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing demand for precision animal medicine, rising investment in veterinary diagnostics innovation, increasing focus on antimicrobial stewardship, expansion of point-of-care testing, growth in animal healthcare expenditure. Major trends in the forecast period include rising demand for integrated therapeutics and diagnostics, increasing focus on early disease detection in animals, growth in preventive animal healthcare practices, expanding use of combination drug therapies, rising adoption of in-clinic diagnostic testing.

Global Animal Therapeutics And Diagnostics Market Segmentation

1) By Product: Therapeutics, Diagnostics, Medical Devices 2) By Animal: Companion Animals, Livestock Animals 3) By Distribution Channel: Retail, E-Commerce, Veterinary Distributors 4) By End-Users: Veterinary Hospitals Or Clinics, Diagnostic Laboratories, Homecare, Other End Users Subsegments: 1) By Therapeutics: Pharmaceuticals, Biologics, Medical Devices Or Therapy Devices 2) By Diagnostics: Point-Of-Care Diagnostics, Laboratory Diagnostics 3) By Medical Devices: Surgical Devices, Wound Care Products, Rehabilitation And Therapy Devices

What Is The Driver Of The Animal Therapeutics And Diagnostics Market?

Rising pet adoption is expected to propel the animal therapeutics and diagnostics market going forward. A pet is a domesticated animal kept primarily for companionship, pleasure, or personal interest, rather than for utility (like farm animals) or research. While pets often form emotional bonds with their owners, they can also serve secondary purposes such as security, pest control, or aesthetic enjoyment. Rising pet adoption is increasing due to a growing emphasis on companionship and mental well-being, with more people seeking pets for emotional support and to alleviate feelings of loneliness, especially in urban environments. The animal therapeutics and diagnostics market supports rising pet adoption, as the growing number of pet owners creates a higher demand for medical treatments, health monitoring, and diagnostic services to ensure pets remain healthy and well-cared-for. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the rising pet adoption rate is driving the animal therapeutics and diagnostics industry.

Key Players In The Global Animal Therapeutics And Diagnostics Market

Major companies operating in the animal therapeutics and diagnostics market are Zoetis Inc., Boehringer Ingelheim Animal Health USA Inc., Virbac AH Inc., Ceva Animal Health Inc., Heska Corporation, IDEXX Laboratories Inc., Bayer Animal Health LLC, Merck & Co. Inc. Animal Health Division, Sanofi-Aventis Animal Health Inc., Elanco Animal Health Incorporated, IDvet, MSD Animal Health, Vetoquinol S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Kindred Biosciences Inc., Neogen Corporation, Abaxis Inc., Pfizer Animal Health, Norbrook Laboratories Limited, BioNote Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., bioMérieux Inc.

Global Animal Therapeutics And Diagnostics Market Trends and Insights

Major companies operating in the animal therapeutics and diagnostics market are developing innovations, such as telemedicine platforms for pet healthcare, to gain a competitive edge in the market. Telemedicine is a healthcare practice that involves the remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technology, such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation launched Zoonivet, a digital pet-care app. This Telehealth platform simplifies pet healthcare by connecting pet parents with qualified veterinarians through video calls, making primary pet care accessible and convenient. Zoonivet also plans to provide surgery, home diagnostic services, medication, pet food, and pet boarding across key Indian markets.

What Are Latest Mergers And Acquisitions In The Animal Therapeutics And Diagnostics Market?

In October 2023, Zomedica, a US-based veterinary health company, announced its acquisition of Qorvo Biotechnologies LLC (QBT) for an undisclosed amount. The acquisition allows Zomedica to incorporate Qorvo's innovative diagnostic technologies into its existing product portfolio. This includes advanced biosensing and diagnostic platforms, which can improve the accuracy and speed of veterinary testing. Qorvo Biotechnologies LLC (QBT) is US-based and specializes in the development of point-of-care (POC) diagnostic solutions.

Regional Outlook

North America was the largest region in the animal therapeutics and diagnostics market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global animal therapeutics and diagnostics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Animal Therapeutics And Diagnostics Market?

The animal therapeutics and diagnostics market includes revenues earned by entities by providing services related to identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses and related technologies such as clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, microbiology, and histopathology tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.